The ets genes family encodes a group of proteins which function as transcription factors under physiological conditions. We report here that the Erg proteins, members of the Ets family, form homo and heterodimeric complexes in vitro. We demonstrate that the Ergp55 protein isoform forms dimers with itself and with the two other isoforms, Ergp49 and Ergp38. Using a set of Erg protein deletion mutants, we de®ne two distinct domains independently involved in dimerization. The ®rst one is located in the amino-terminal part of the protein containing the pointed domain (PNT), conserved in a subset of Ets proteins. The second one resides within the ETS domain, the DNA-binding domain. We also show that the Erg protein central region behaves as an inhibitory domain of dimerization and its removal enhances the Ergp55 transactivation properties. Furthermore, Ergp55 forms heterodimers with some other Ets proteins. Among the latter, we show that Fli-1, Ets-2, Er81 and Pu-1 physically interact with Erg. Finally, we show that the formation of the previously described ternary complex Ergp55/Fos/jun is mediated by ETS domain and Jun protein, while the ternary complex Ergp49/Fos/Jun is mediated by Fos protein.
Introduction
The ets family contains a large number of genes that encode related transcriptional regulators involved in a variety of developmental mechanisms (CreÂ pieux et al., 1994) . The proto-oncogene c-ets1 is the cellular progenitor of the v-ets oncogene of the avian leukemia virus E26 and the founder member of the burgeoning ets family (Leprince et al., 1983; Nunn et al., 1983) . The common feature of all Ets proteins is their DNA-binding domain (85 amino acid residues), named ETS domain and structured as a winged helix ± turn ± helix motif (Donaldson et al., 1994 (Donaldson et al., , 1996 Liang et al., 1994; Kodandapani et al., 1996) . This domain can bind to the purine rich GGA(A/T) core sequence (Karim et al., 1990; Wasylyk et al., 1990) . In addition, a second domain is conserved in a subset of Ets proteins, Ets-1, Ets-2, Erg, Fli-1, Gabpa and Tel in vertebrates and Pnt, Elg and Yan in Drosophila. This region of about 65 amino acid residues, localized in the amino-terminal part of the Ets proteins, has been referred as the pointed domain (PNT) (KlaÈ mbt, 1993) . A recent alignment reveals that it is related to a region present in Polycomb protein family and in cytoplasmic proteins involved in yeast sexual dierentiation (Borneman et al., 1996; Alkema et al., 1996; Graves and Petersen, 1998) , so it was named SEP (yeast Sterility, Ets-related, Polycomb proteins). It was previously described as a putative HLH domain because of a weak resemblance to the helix ± loop ± helix motif (Seth and Papas, 1990 ) but recent secondary structure data reveal that the structure does not match a HLH motif (C Slupsky, L Gentile, L Donaldson, C Mackereth, J Seitel, B Graves and L McIntosh; personal communication) . In this report, we will name this conserved region PNT domain. However, in Ets family, no clear function has been associated with this domain except in Tel protein, where it is able to mediate speci®c oligomerization of Tel (Jousset et al., 1997) .
We have focused our attention on the erg gene, a member of the ets family, which encodes at least ®ve proteins, Erg-1, Erg-2, Ergp55, Ergp49 and Ergp38 as a result of dierential splicing, polyadenylation or initiation codon. These protein isoforms are weak transactivators and present similar properties of binding and transactivation Reddy et al., 1987; Duterque-Coquillaud et al., 1993) . We have previously shown that Ergp55, one of the isoforms encoded by the human erg gene, could dierentially regulate the two matrix-metalloproteinase promoters of collagenase1 and stromelysin1 (ButticeÁ et al., 1996) . We found a functional antagonism between Ergp55 and Ets-2 proteins where Ergp55 does not activate the human stromelysin1 but can repress the activation by Ets-2. This antagonism can not be explained by dierential DNA-binding anity for the double EBS (Ets Binding Site) since both Ergp55 and Ets-2 bind these sites. We suggested a possible mechanism of interaction between the Ergp55 and Ets-2 proteins. By contrast to stromelysin1, Ergp55 activates human collagenasel promoter and is able to cooperate with Fos/Jun complex via functional EBS and AP1 sites. This cooperation involved protein interaction between Ergp55 and AP1 complex.
In the present study, we show that Erg protein isoforms encoded by the human erg gene are able to form heterodimers with some, but not all, Ets proteins. We also demonstrate that they are able to form homodimers via two distinct domains. We found that the ETS domain is involved in the formation of ternary complex Erg/Fos/Jun and that this formation is directed by dierent AP1 partners for the various Erg isoforms.
Results and discussion

Formation of dimeric complexes by Erg and Ets proteins in vitro
Our previous regulation studies on human stromelysin1 promoter have recently revealed that Erg is able to repress Ets-2 activation (ButticeÁ et al., 1996) . One of the possible mechanisms for this antagonism might be a physical interaction between Erg and Ets-2 proteins (Basuyaux et al., 1997) . To test whether the Erg and other Ets proteins form homo and heterodimeric complexes in vitro, we performed pull-down assays between GST-Ergp55, one of the ®ve isoforms encoded by the human erg gene fused to the GST protein, and various Erg derived proteins (Figure 1) or Ets family members. First, as shown in Figure 2a (lanes 6 ± 8),
GST-Ergp55 interacted with Ergp55 itself and with the two Erg isoforms tested, Ergp49 and Ergp38, but not with luciferase (lane 10) or GST alone (lanes 11 ± 15). In order to con®rm these homodimerizations, we performed co-immunoprecipitation assays with GST ± Ergp55 incubated with 35 S-labeled in vitro translated proteins. Complexes were precipitated by a GSTspeci®c monoclonal antibody. Each protein isoform co-precipitated with GST ± Ergp55 (data not shown). Second, we also showed that Fli-1 protein, the most closely Erg related member among the Ets proteins, was able to interact with GST ± Ergp55 (Figure 2a, lane  9) . In order to see if more distantly related proteins in the same family were also able to interact with Erg protein, we performed additional pull down assays with several other Ets proteins. Among the proteins tested, only Ets-2, Fli-1, Er81 and Pu-1 proteins Figure 1 Schematic structure of proteins used in this study. Ergp55, Ergp49 and Ergp38 correspond to three human Erg isoforms. The ETS domain is shown as a black box and the alternative exons as hatched boxes. PNT is the amino-terminal domain conserved in Ets-1, Ets-2, Erg, Fli-1, Gabpa (Xin et al., 1992) , and ck-Pu-1 (Kherrouche et al., 1998) . (c) Ergp55 homodimerization involves two independant interaction domains. The input lanes contained 10% of the 35 S-labeled proteins used in the interaction assays. Note the lack of Ets protein binding to GST alone and luciferase (Luc), as negative controls interacted signi®cantly with Ergp55 (Figure 2b, lanes 13, 15, 19 and 21) . The interaction with Er81 and Pu-1, which do not have the amino-terminal conserved PNT domain, demonstrated that this domain is not essential for heterodimerization. Poor or no interaction was detected with Ets-1, Elk-1, Erm, Etv-1 and Pea3 proteins (Figure 2b, lanes 12, 16 ± 18 and 20) indicating that the ETS domain shared by all Ets proteins is not sucient for interaction. These results suggest that unconserved domains, perhaps involved in conformational structures of these proteins, are essential for heterodimerization.
To summarize these interactions, three types of complexes were formed: (i) homodimeric complexes between individual Ergp55; (ii) homo-iso-dimeric complexes between Ergp55 and various Erg isoforms; (iii) heterodimeric complexes between Ergp55 and members of the Ets family. However, our experiments do not allow us to rule out either possible oligomerization or multimerization of Erg and Ets proteins as it has been suggested for other Ets proteins (Jousset et al., 1997) . Moreover, in mobility shift assays, no altered mobility of complexes were observed using various Ets Binding Sites incubated with a full length Erg protein and neither other Ets proteins nor Erg protein mutants (data not shown). This observation con®rms that Ets proteins recognize DNA as monomers (Nye et al., 1992) and suggests that dimeric or multimeric forms are inactive.
Homodimerization of Erg proteins involves two distinct protein domains
In order to de®ne the domain responsible for the homodimerization, we used a series of truncated Erg proteins for another set of experiments ( Figure 1 ). In Figure 2c , we showed that 49 1 ± 190 mutant (lane 7), which corresponds to the amino-terminal part of the Ergp55 or Ergp49 proteins, was able to bind GST ± Ergp55 in a way similar to Ergp55. Moreover, the 55 307 ± 479 mutant (lane 9), which corresponds to the carboxy-terminal part of Ergp55 with the ETS domain, was also able to bind GST ± Ergp55. Using a Ergp55 protein mutant deleted in its ETS domain, named 55 D307 ± 392 (lane 10), no interaction was detectable suggesting that the ETS domain is necessary for Erg proteins homodimerization. Conservatively, the deletion of the carboxy-terminal part of the protein in Erg (55 1 ± 433 and 49 1 ± 433 mutants) did not aect the interaction with GST ± Ergp55 (data not shown). We therefore concluded that the Ergp55 protein can homodimerize through two distinct and independent domains, located either in the aminoterminal part or in the carboxy-terminal part including the ETS domain. The amino-terminal part of the Ergp55 protein required for interaction is located in the 200 ®rst residues. This region comprises the PNT domain which was recently described to be sucient for oligomerization of Tel protein, a member of the Ets family (Jousset et al., 1997) . This property has been described to be speci®c of Tel protein. By contrast, Ets-2 protein, which contains the PNT domain, appears unable to homodimerize (Basuyaux et al., 1997) . Moreover, the SEP domain previously described in Polycomb protein family and in cytoplasmic proteins involved in yeast sexual differentiation, related to PNT, has been shown to be involved in protein interactions (Borneman et al., 1996; Gunster et al., 1997) .
To investigate the role of the alternative exons in dimerization, we used the 55 1 ± 306 mutant, comprising the region coded by central alternative exons (CAE) and central domain (CD) of the Erg protein. The absence of interaction with GST ± Ergp55 (Figure 2c , lane 8) suggested that CD (aa 249 ± 306) could behave as an inhibitory domain for the interaction of Erg amino-terminal part with Ergp55. Moreover, CAE seemed to act in connection with this central region since 55 D249 ± 308 interacted with GST ± Ergp55 but 49 D249 ± 308 did not (data not shown). These observations also suggest that the inhibitory eect of CD acts on dimerization through amino-terminal part of Erg protein but not when both amino and carboxyterminal parts are present (55 D249 ± 308 ). These observations also suggest conformational dierences, in the presence or absence of CAE and CD, potentially associated with distinct intramolecular interactions. The absence of both CAE and CD in 49 D249 ± 308 mutant may drastically modify the protein conformation and prevent dimers formation.
Negative in¯uence of the central domain (CD) of Erg proteins on transactivation
As an approach to the relevance of the detected interactions, we next investigated the functional consequences of Erg protein deletions on their respective transcriptional activities. The deletion mutants used in this study were analysed for their DNA-binding speci®city and no signi®cant dierence was observed between them (data not shown). We excluded the 49 D249 ± 308 mutant which failed to bind to a canonical Ets binding site. Transient transfections were performed with Cos-1 and HepG2 cell lines by using a reporter plasmid containing four copies of the arti®cial Py enhancer consensus element (Pye) cloned upstream of the TK promoter and a luciferase reporter gene (Figure 3a) . Similar results were obtained in both cell lines. The Pye, containing EBS and AP1 sites, has previously been shown to be regulated by Ets protein (Gutman and . As shown in Figure 3a , transfection of the Ergp55 expression plasmid resulted in signi®cant transcriptional activation of the Pye reporter plasmid (20-fold) compared with transfection of the Ergp49 and Ergp38 expression plasmids (tenfold). The transactivation eect of these two isoforms was comparable with the eect induced by the two Erg protein mutants (55 1 ± 433 and 49 1 ± 433 ) deleted in their carboxy-terminal part. Moreover, the deletion of the amino-terminal moiety of Erg proteins comprising CAE and CD (55 307 ± 479 ), also showed transactivation eect (about eightfold). These results con®rm the presence of the carboxy-terminal transcriptional activation domain previously described (Siddique et al., 1993) . The CD deletion (55 D249 ± 308 ) confered to the mutant protein a better transactivation capacity on the Pye element than Ergp55 wild type protein. These results suggest that CD which acts as an inhibitory domain on dimerization, plays an inhibitory role in transcriptional activation by Erg proteins.
The Erg protein interacts with the AP1 complex via DNA-binding domain
We have previously shown that Ergp55 interacted with an AP1 complex (ButticeÁ et al., 1996) . In GST pull-down assays, we co-incubated either Fos and Jun proteins alone or both proteins together with GST ± Ergp55 protein (Figure 4) . Thus, we con®rmed that Ergp55 interacted principally with Fos/Jun complex (Figure 4, lane 7) and that a low interaction was detectable with Jun protein alone (lane 6) and no interaction with Fos protein alone (lane 5). Since several Ets proteins have been described to interact with AP1 complex (Bassuk and Leiden, 1995) , we further investigated the involvement of the ETS domain in these interactions. As shown in Figure 4 , a GST ± DETS mutant which corresponds to GST ± Ergp55 protein without a region including the ETS domain (Figure 1 ) was unable to interact either with Fos and Jun proteins alone (lanes 9 and 10) or with Fos/Jun complex (lane 11). In parallel, we also studied the ability of Ergp49 to interact with AP1 complex. Surprisingly, by contrast with GST ± Ergp55, GST ± Ergp49 was able to strongly interact not only with AP1 complex (lane 15) but also with Fos and Jun proteins alone (lanes 13 and 14) . The Ergp49 isoform which lacks the two central alternative exons (CAE) is the ®rst Ets protein able to interact with Fos protein alone since all the Ets proteins studied so far interact with Jun family proteins (Bassuk and Leiden, 1995) . This result constituted the ®rst functional dierence observed between Erg protein isoforms which usually exhibit similar properties.
In conclusion, the ETS domain of Ergp55 protein appears involved in the formation of a ternary complex with Fos/Jun. Thus this observation taking together with the mapping of the Erg domains responsible for the homodimerization shows that the ETS domain serves a key dual function, DNA-binding and in protein ± protein interactions. It is also the case for other transcriptional factors, for example, the Runt family proteins are able to physically interact with other factors via their RUNT domain, also responsible of DNA-binding properties (Ogawa et al., 1993; Giese et al., 1995) .
The carboxy-terminal part of Erg proteins, comprising the ETS domain, is sucient to mediate Erg/AP1 cooperation
We and other have previously shown that Ets proteins and AP1 complex can cooperatively activate transcription from a reporter construct containing a promoter or a enhancer element Gutman and Wasylyk, 1990; ButticeÁ et al., 1996) . Human collagenase1 promoter contains adjacent EBS and AP1 sites, both of which are required for this cooperative transcriptional regulation (ButticeÁ et al., 1996) . To assess directly the functional role of the physical interaction between Erg proteins and AP1 complex, we performed a series of transient transfection assays in which we compared the ability of the wild-type Erg isoforms and their deletion mutants to activate collagenase1 promoter transcription cooperatively with Fos and Jun proteins. We transfected Cos-1 cells with a luciferase reporter construct containing collagenasel promoter in conjunction with various combinations of Erg and Fos/Jun proteins ( Figure  3b) . Overexpression of the three Erg isoforms tested alone resulted in similar transactivation eect, respectively ®ve-, four-and sixfold. Overexpression of Fos/ Jun proteins alone resulted in threefold transactivation eect. Co-transfection of Ergp55, Ergp49, Ergp38 and Fos/Jun proteins resulted in 20-, 16-and 13-fold transactivation respectively which revealed a cooperative eect of these factors. Similar results were described with others Ets proteins family on an arti®cial promoter (Bassuk and Leiden, 1995) . Cotransfection of Fos/Jun proteins with the 55 307 ± 479 mutant, which corresponds to the carboxy-terminal part of Erg proteins comprising the ETS domain, resulted in a 18-fold transactivation. This result demonstrated that this part of Erg proteins, which is involved in physical interaction between Erg and Fos/ Jun proteins, is sucient to mediate Erg/AP1 cooperation. However, co-transfection of various Erg mutants with Fos/Jun indicated that cooperative transactivation by these factors was modulated by other domains without direct implication in protein interaction. First, the absence of the carboxy-terminal part of Ergp55 and Ergp49 (55 1 ± 433 and 49 1 ± 433 mutants) resulted in a reduction of their cooperative eect with AP1 complex (ten-and 14-fold). Second, CD acted as an inhibitory domain of cooperation since co-transfection with 55 D249 ± 308 mutant resulted in a better cooperative eect than with the wild-type Ergp55 (24-fold), these results are in favor of conformation in¯uence of the Erg isoforms where CD is possibly involved in speci®c protein interactions. In Figure 5 , we summarize the functions of the Ergp55 domains de®ned in this paper.
Concluding remarks
Based on these observations, we can envisage several models concerning the functional consequences of Erg heterodimerization with Ets proteins. First, formation of heterodimeric complexes between members of the same family could be a mean to regulate their transcriptional activity. For example, Erg/Ets-2 dimer formation may prevent Ets-2 protein from acting as transcriptional activator, as it was previously shown on stromelysin1 promoter (ButticeÁ et al., 1996; Basuyaux et al., 1997) . In this case, monomeric proteins would be functionally active while heterodimeric complexes would be inactive by masking their transactivation domains or modulating their availability to accessory protein factors or other transcription factors like AP1. Second, dimerization may prevent Ets proteins from binding to genomic DNA target sites since Ets proteins have always been described to bind in monomer form (CreÂ pieux et al., 1994) . Therefore, these two possibilities are not mutually exclusive but could be complementary. Moreover, various conditions would necessarily modulate these regulatory interactions. One of them is the competition for homodimerization versus heterodimerization which depends on the relative intracellular concentrations of Ets proteins. Another one concerns the accessibility and the anity of DNA target sites for maintaining the appropriate balance of active monomers relative to inactive dimers.
In other respects, we and others have previously shown that ets-1, erg and¯i-1 are co-expressed during chicken or mouse embryo development, particularly in mesenchyme, blood vessel formation and neural crest cell migration (Vandenbunder et al., 1989; Dhordain et al., 1995; MeÂ let et al., 1996) . Particularly, ets-2 and erg are co-expressed in cartilaginous tissue during chicken and mouse embryonic development (Maroulakou et al., 1994; Dhordain et al., 1995) . Based both on their overlapping spatiotemporal expression patterns during embryogenesis and on our biochemical data, we propose that the Ets proteins ability to heterodimerize to each other provides a regulatory mechanism by which Ets proteins mutually regulate their transcriptional actions in vivo. Similar regulation models have been proposed in various transcription factor families. Indeed, for example, Msx and D1x homeoproteins, which exhibit overlapping expression patterns, form heterodimers with respect to their functional antagonism (Zhang et al., 1997) . Moreover, TBP dimerization have been shown to inhibit DNA-binding and, consequently, to provide a mode of regulating TBP-DNA interaction (Taggart and Pugh, 1996) . The similarity of these observations and our results raises the possibility that formation of inactive homo or heterodimers could be a general mode of regulating transcription factors activity in vivo.
Materials and methods
Plasmid constructs
In order to construct recombinant pGEX-2TK (Pharmacia), the cDNA encoding Ergp55 and Ergp49 were ampli®ed by PCR, using pSG5-HuErgp55 and pSG5-HuErgp49 as template (Duterque-Coquillaud et al., 1993) , with the 5' amplimer 5'-GAGGATCCCGGGTATGGC-CAGCACTATTAAG and the 3' amplimer 5'-TTGA-GTCCCGGGTCTTTAGTAGTAAGTGC. Each amplimer contained SmaI sites, such that the resulting PCR products ®rst subcloned into pCRII (Invitrogen), and could be ligated, upon digestion with SmaI, in frame into the unique Smal site present within the pGEX-2TK polylinker. The recombinant pGEX-2TK containing cDNA encoding Ergp55 was digested by NdeI restriction enzyme and religated to delete the ETS domain coding region.
Deletion mutants were obtained by PCR ampli®cation and subcloned into pCRII. Mutants 55 1 ± 306 and 49 1 ± 90 were cloned via EcoRI sites into pSG5. Template was Ergp55 cDNA for all 55 x-y mutants and Ergp49 cDNA for all 49 x-y mutants. The 5' amplimer was 5'-AGACAGATCTCAATAAACTTGAT-TGC and the 3' amplimers was, 5'-ACTTCATGGATTTG-CAAGGCGGCTACTTG for 55 1 ± 306 mutant and 5'-CCT-GGGGGCTCATATGGTTAAT for 49 1 ± 190 mutant. The 55 1 ± 433 , 49 1 ± 433 , 55 D307 ± 392 , 55 D249 ± 308 and 49 D249 ± 308 mutants were cloned via BglII sites into pSG5. The 5' amplimer was still the same. For 55 1 ± 433 and 49 1 ± 433 , the 3' amplimer was 5'-AG-ATCTACAAAGTTCATCTTCTGT. For 55 D307 ± 392 , 55 D249 ± 308 and 49 D249 ± 308 , the 3' amplimer was 5'-CTAGATCTCT-TCCCCGGCTTCC; the internal amplimers were 5'-GCC-GCCTTGCAAATCCAGACTTCCAGGGGATCGCCCAG-GCC for 55 D307 ± 392 5'-CTGGATCTGGCCACTGCCTGGC-CTAGTTGTAATTCT for 55 D249 ± 308 and 5'-CTGGATCTG-GCCA CTGCCCTCTCTGAGGTAGTGGAG for 49 D249 ± 308 . Mutant 55 307 ± 479 was cloned via EcoRI sites into pSG5. The 5' amplimer was 5'-AGATCTGCATTATGGCCGGCAGT-GGCCAGATCCAGC and the 3' amplimer was 5'-CTA-GATCTCTTCCCCGGCTTCC.
In vitro proteins synthesis
The in vitro T7 driver transcription and translation of the cDNAs were simultaneously performed using TNT coupled reticulocyte lysate system and [
35 S]methionine, according to the instructions of manufacturer (Promega). The translation products were visualized in SDS ± PAGE and quanti®ed by Phosphor Imager (Molecular Dynamics).
GST fusion proteins were isolated from E. coli XL1blue bacteria containing the appropriate expression vectors. 20 ml of an overnight culture was inoculated into 11 of 2XYT and incubated at 378C until an absorption of 1 at 600 nm was reached. Isopropyl-D-galactopyranoside (Boehringer) was added to 1 mM ®nal concentration and the culture was incubated for additional 5 h. After centrifugation, bacterial pellet was suspended in 10 ml PBS-Triton X-100 1% containing a quarter of a protease inhibitors cocktail tablet (Boehringer) and lysed by passing through a French press twice. After centrifugation at 10 000 g for 10 min at 48C, DNAseI (Boehringer) was added to 1 mM ®nal concentration to the supernatant containing soluble proteins. GST fusion proteins were then puri®ed on glutathione-Sepharose beads column (Pharmacia) in accordance with the manufacturer's instructions. The concentrations and purities of the GST fusion proteins were estimated by SDS ± PAGE, followed by Coomassie blue staining.
Pull-down assays 50 ml of Glutathione Sepharose beads (Pharmacia) were incubated with 1 mg of either GST or GST ± Ergp55 or GST ± Ergp49 or GST ± DETS fusion proteins in NETN (20 mM Tris HCl pH 8, 100 mM NaCl, 1 mM EDTA, 0.5% NP40), for 1 h at 48C. Beads were washed three times with incubation buer (12 mM HEPES pH 7.9, 4 mM Tris HCl pH 7.9, 50 mM NaCl, 10 mM KCl, 1 mM EDTA) and resuspended in 30 ml of a mixture containing 35 S-labeled protein expressed in reticulocyte lysate and incubation buer. After 1 h at 48C, beads were washed ®ve times with NETN and mixed with SDS-sample buer. The bound proteins were analysed by SDS ± PAGE followed by autoradiography.
Transactivation assays
Human HepG2 hepatocarcinoma cells (H8065) from American Type Culture Collection and Cos-1 cells were cultured for 24 h in DMEM (Life Technologies Inc.) containing 10% fetal calf serum (FCS), gentamycin (100 units/ml). They were rinsed and incubated in 1 ml of OptiMEM (Life Technologies, Inc.) with a mixture of DNA (maximal amount 1 mg) and Poly Ethylene Imine (4 ml, Euromedex). In each experiment, plates were incubated with the same total plasmid amount (1 mg) completed as necessary with the corresponding empty vector. Cells were incubated overnight, harvested and disrupted in lysis buer (Promega). The supernatant was assayed for protein content (Bio-Rad protein assay) and processed for luciferase assay. Reaction mixtures, containing 20 ml of cell extract and 80ml of luciferase assay buer (25 mM Tris phosphate pH 7.8, 8 mM MgCl 2 , 1 mM DTT, Triton X-100 1% v/v) were measured in a Berthold Lumat LB9501 luminometer following injection of luciferine assay solution (0.25 mM luciferine and 2 mM ATP in luciferase assay buer). Triplicate samples were performed in two or three experiments, and the values obtained were veri®ed by normalization to the proteins content of each cell extract. In addition, we used pSV2-Luc plasmid as positive control of transfection. For each protein expression vector transiently transfected in the two cell lines used in this study, their expression level was shown similar by immunoprecipitating labeled protein extracts with Erg speci®c polyclonal antibodies (Dhordain et al., 1995) .
